Mouse Bag2 Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Bag2 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Bag2 Knockout Project (CRISPR/Cas9) Objective: To create a Bag2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Bag2 gene (NCBI Reference Sequence: NM_145392 ; Ensembl: ENSMUSG00000042215 ) is located on Mouse chromosome 1. 3 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 3 (Transcript: ENSMUST00000044691). Exon 1~3 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 1 starts from about 0.16% of the coding region. Exon 1~3 covers 100.0% of the coding region. The size of effective KO region: ~12080 bp. The function of mouse Gm37905 will be affected by deleting this KO region.. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 Legends Exon of mouse Bag2 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Page 3 of 8 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(25.2% 504) | C(24.15% 483) | T(24.75% 495) | G(25.9% 518) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. Significant high GC-content regions are found. The gRNA site is selected outside of these high GC-content regions. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(24.2% 484) | C(26.45% 529) | T(28.7% 574) | G(20.65% 413) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr1 - 33757692 33759691 2000 browser details YourSeq 84 770 1043 2000 91.3% chr11 - 61646044 61646357 314 browser details YourSeq 79 790 1038 2000 91.6% chr18 + 4843541 4843839 299 browser details YourSeq 77 790 1043 2000 93.4% chr4 + 111764747 111765044 298 browser details YourSeq 75 805 1043 2000 88.7% chr14 - 70813743 70814026 284 browser details YourSeq 65 755 910 2000 86.6% chr18 - 24023511 24023706 196 browser details YourSeq 64 760 857 2000 83.7% chr16 - 21101399 21101598 200 browser details YourSeq 63 754 1039 2000 87.1% chr9 - 60986467 60986798 332 browser details YourSeq 63 754 982 2000 85.4% chr11 - 20842630 20843036 407 browser details YourSeq 63 753 1043 2000 86.3% chr1 - 170641513 170641885 373 browser details YourSeq 63 754 1043 2000 84.7% chr11 + 70817184 70817550 367 browser details YourSeq 63 900 1043 2000 92.0% chr10 + 89441416 89441596 181 browser details YourSeq 62 757 1041 2000 88.8% chr3 - 154095462 154095798 337 browser details YourSeq 62 754 1038 2000 90.8% chr13 + 35711595 35711970 376 browser details YourSeq 62 754 941 2000 94.5% chr10 + 72579936 72580144 209 browser details YourSeq 61 756 848 2000 85.9% chr9 - 118800451 118800546 96 browser details YourSeq 59 804 1042 2000 94.1% chr1 + 90316703 90316988 286 browser details YourSeq 57 924 1044 2000 92.6% chr6 - 24705210 24705332 123 browser details YourSeq 56 752 863 2000 76.1% chr13 + 38754138 38754227 90 browser details YourSeq 54 754 824 2000 92.2% chr1 + 75990076 75990149 74 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr1 - 33744610 33746609 2000 browser details YourSeq 278 1242 1808 2000 96.4% chr10 + 128101400 128170377 68978 browser details YourSeq 275 1242 1808 2000 91.0% chr19 + 37478341 37478677 337 browser details YourSeq 271 1238 1811 2000 95.4% chr1 + 136649465 136650049 585 browser details YourSeq 270 1241 1807 2000 88.9% chr7 - 127243031 127243384 354 browser details YourSeq 264 1242 1807 2000 86.4% chr16 + 91484123 91484456 334 browser details YourSeq 256 1249 1822 2000 91.1% chr17 - 29515518 29516074 557 browser details YourSeq 255 1249 1809 2000 88.7% chr17 - 33893664 33893992 329 browser details YourSeq 246 1242 1808 2000 88.3% chr4 - 133760470 133760958 489 browser details YourSeq 241 1255 1808 2000 88.9% chr6 + 51519549 51519888 340 browser details YourSeq 237 1238 1808 2000 88.3% chr10 - 62579141 62579462 322 browser details YourSeq 237 1238 1808 2000 89.3% chr11 + 72801771 72802142 372 browser details YourSeq 236 1238 1808 2000 90.6% chr11 + 80452630 80453142 513 browser details YourSeq 229 1268 1808 2000 88.0% chr11 - 97272356 97272854 499 browser details YourSeq 219 1286 1808 2000 89.4% chr11 - 3314643 3315100 458 browser details YourSeq 207 1238 1808 2000 93.7% chr9 - 65778205 65778798 594 browser details YourSeq 205 1244 1808 2000 88.6% chr11 - 20029651 20030041 391 browser details YourSeq 203 1301 1807 2000 93.6% chr19 - 45339616 45340205 590 browser details YourSeq 198 1310 1822 2000 98.1% chr10 + 128052046 128052670 625 browser details YourSeq 178 1636 1845 2000 96.4% chrX + 162723681 162724170 490 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 8 https://www.alphaknockout.com Gene and protein information: Bag2 BCL2-associated athanogene 2 [ Mus musculus (house mouse) ] Gene ID: 213539, updated on 12-Aug-2019 Gene summary Official Symbol Bag2 provided by MGI Official Full Name BCL2-associated athanogene 2 provided by MGI Primary source MGI:MGI:1891254 See related Ensembl:ENSMUSG00000042215 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as BC016230; 2610042A13Rik Expression Ubiquitous expression in bladder adult (RPKM 26.9), placenta adult (RPKM 26.6) and 28 other tissues See more Orthologs human all Genomic context Location: 1; 1 B See Bag2 in Genome Data Viewer Exon count: 4 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 1 NC_000067.6 (33745484..33757750, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 1 NC_000067.5 (33802329..33814595, complement) Chromosome 1 - NC_000067.6 Page 6 of 8 https://www.alphaknockout.com Transcript information: This gene has 4 transcripts Gene: Bag2 ENSMUSG00000042215 Description BCL2-associated athanogene 2 [Source:MGI Symbol;Acc:MGI:1891254] Gene Synonyms 2610042A13Rik Location Chromosome 1: 33,745,484-33,757,795 reverse strand. GRCm38:CM000994.2 About this gene This gene has 4 transcripts (splice variants), 197 orthologues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Bag2-201 ENSMUST00000044691.8 1860 210aa ENSMUSP00000042009.7 Protein coding CCDS14864 Q91YN9 TSL:1 GENCODE basic APPRIS P1 Bag2-203 ENSMUST00000187602.1 378 57aa ENSMUSP00000139538.1 Protein coding - A0A087WNX9 TSL:2 GENCODE basic Bag2-204 ENSMUST00000189741.1 955 No protein - Retained intron - - TSL:NA Bag2-202 ENSMUST00000155484.1 781 No protein - Retained intron - - TSL:2 32.31 kb Forward strand 33.74Mb 33.75Mb 33.76Mb Genes Rab23-201 >protein coding Gm37905-201 >TEC (Comprehensive set... Rab23-206 >nonsense mediated decay Rab23-202 >protein coding Rab23-208 >retained intron Rab23-203 >retained intron Rab23-204 >retained intron Contigs < AC163668.5 Genes (Comprehensive set... < Bag2-201protein coding < Zfp451-206nonsense mediated decay < Bag2-202retained intron < Bag2-204retained intron < Zfp451-201protein coding < Bag2-203protein coding Regulatory Build 33.74Mb 33.75Mb 33.76Mb Reverse strand 32.31 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000044691 < Bag2-201protein coding Reverse strand 12.31 kb ENSMUSP00000042... PDB-ENSP mappings Coiled-coils (Ncoils) SMART BAG domain PROSITE profiles BAG domain PANTHER BAG family molecular chaperone regulator 2 Gene3D 1.20.58.890 CDD cd17282 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant splice region variant synonymous variant Scale bar 0 20 40 60 80 100 120 140 160 180 210 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Recommended publications
  • A Cell Line P53 Mutation Type UM
    A Cell line p53 mutation Type UM-SCC 1 wt UM-SCC5 Exon 5, 157 GTC --> TTC Missense mutation by transversion (Valine --> Phenylalanine UM-SCC6 wt UM-SCC9 wt UM-SCC11A wt UM-SCC11B Exon 7, 242 TGC --> TCC Missense mutation by transversion (Cysteine --> Serine) UM-SCC22A Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC22B Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC38 Exon 5, 132 AAG --> AAT Missense mutation by transversion (Lysine --> Asparagine) UM-SCC46 Exon 8, 278 CCT --> CGT Missense mutation by transversion (Proline --> Alanine) B 1 Supplementary Methods Cell Lines and Cell Culture A panel of ten established HNSCC cell lines from the University of Michigan series (UM-SCC) was obtained from Dr. T. E. Carey at the University of Michigan, Ann Arbor, MI. The UM-SCC cell lines were derived from eight patients with SCC of the upper aerodigestive tract (supplemental Table 1). Patient age at tumor diagnosis ranged from 37 to 72 years. The cell lines selected were obtained from patients with stage I-IV tumors, distributed among oral, pharyngeal and laryngeal sites. All the patients had aggressive disease, with early recurrence and death within two years of therapy. Cell lines established from single isolates of a patient specimen are designated by a numeric designation, and where isolates from two time points or anatomical sites were obtained, the designation includes an alphabetical suffix (i.e., "A" or "B"). The cell lines were maintained in Eagle's minimal essential media supplemented with 10% fetal bovine serum and penicillin/streptomycin.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Bag6 Complex Contains a Minimal Tail-Anchor–Targeting Module and a Mock BAG Domain
    Bag6 complex contains a minimal tail-anchor–targeting module and a mock BAG domain Jee-Young Mocka, Justin William Chartrona,Ma’ayan Zaslavera,YueXub,YihongYeb, and William Melvon Clemons Jr.a,1 aDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; and bLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved December 1, 2014 (received for review February 12, 2014) BCL2-associated athanogene cochaperone 6 (Bag6) plays a central analogous yeast complex contains two proteins, Get4 and Get5/ role in cellular homeostasis in a diverse array of processes and is Mdy2, which are homologs of the mammalian proteins TRC35 part of the heterotrimeric Bag6 complex, which also includes and Ubl4A, respectively. In yeast, these two proteins form ubiquitin-like 4A (Ubl4A) and transmembrane domain recognition a heterotetramer that regulates the handoff of the TA protein complex 35 (TRC35). This complex recently has been shown to be from the cochaperone small, glutamine-rich, tetratricopeptide important in the TRC pathway, the mislocalized protein degrada- repeat protein 2 (Sgt2) [small glutamine-rich tetratricopeptide tion pathway, and the endoplasmic reticulum-associated degrada- repeat-containing protein (SGTA) in mammals] to the delivery tion pathway. Here we define the architecture of the Bag6 factor Get3 (TRC40 in mammals) (19–22). It is expected that the complex, demonstrating that both TRC35 and Ubl4A have distinct mammalian homologs, along with Bag6, play a similar role (23– C-terminal binding sites on Bag6 defining a minimal Bag6 complex.
    [Show full text]
  • Senescence Inhibits the Chaperone Response to Thermal Stress
    SUPPLEMENTAL INFORMATION Senescence inhibits the chaperone response to thermal stress Jack Llewellyn1, 2, Venkatesh Mallikarjun1, 2, 3, Ellen Appleton1, 2, Maria Osipova1, 2, Hamish TJ Gilbert1, 2, Stephen M Richardson2, Simon J Hubbard4, 5 and Joe Swift1, 2, 5 (1) Wellcome Centre for Cell-Matrix Research, Oxford Road, Manchester, M13 9PT, UK. (2) Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (3) Current address: Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, VA, 22903, USA. (4) Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (5) Correspondence to SJH ([email protected]) or JS ([email protected]). Page 1 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence CONTENTS Supplemental figures S1 – S5 … … … … … … … … 3 Supplemental table S6 … … … … … … … … 10 Supplemental references … … … … … … … … 11 Page 2 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence SUPPLEMENTAL FIGURES Figure S1. A EP (passage 3) LP (passage 16) 200 µm 200 µm 1.5 3 B Mass spectrometry proteomics (n = 4) C mRNA (n = 4) D 100k EP 1.0 2 p < 0.0001 p < 0.0001 LP p < 0.0001 p < 0.0001 ) 0.5 1 2 p < 0.0001 p < 0.0001 10k 0.0 0 -0.5 -1 Cell area (µm Cell area fold change vs. EP fold change vs.
    [Show full text]
  • LOXL1 Confers Antiapoptosis and Promotes Gliomagenesis Through Stabilizing BAG2
    Cell Death & Differentiation (2020) 27:3021–3036 https://doi.org/10.1038/s41418-020-0558-4 ARTICLE LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2 1,2 3 4 3 4 3 1 1 Hua Yu ● Jun Ding ● Hongwen Zhu ● Yao Jing ● Hu Zhou ● Hengli Tian ● Ke Tang ● Gang Wang ● Xiongjun Wang1,2 Received: 10 January 2020 / Revised: 30 April 2020 / Accepted: 5 May 2020 / Published online: 18 May 2020 © The Author(s) 2020. This article is published with open access Abstract The lysyl oxidase (LOX) family is closely related to the progression of glioma. To ensure the clinical significance of LOX family in glioma, The Cancer Genome Atlas (TCGA) database was mined and the analysis indicated that higher LOXL1 expression was correlated with more malignant glioma progression. The functions of LOXL1 in promoting glioma cell survival and inhibiting apoptosis were studied by gain- and loss-of-function experiments in cells and animals. LOXL1 was found to exhibit antiapoptotic activity by interacting with multiple antiapoptosis modulators, especially BAG family molecular chaperone regulator 2 (BAG2). LOXL1-D515 interacted with BAG2-K186 through a hydrogen bond, and its lysyl 1234567890();,: 1234567890();,: oxidase activity prevented BAG2 degradation by competing with K186 ubiquitylation. Then, we discovered that LOXL1 expression was specifically upregulated through the VEGFR-Src-CEBPA axis. Clinically, the patients with higher LOXL1 levels in their blood had much more abundant BAG2 protein levels in glioma tissues. Conclusively, LOXL1 functions as an important mediator that increases the antiapoptotic capacity of tumor cells, and approaches targeting LOXL1 represent a potential strategy for treating glioma.
    [Show full text]
  • CLIP2 As Radiation Biomarker in Papillary Thyroid Carcinoma
    Oncogene (2015) 34, 3917–3925 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc ORIGINAL ARTICLE CLIP2 as radiation biomarker in papillary thyroid carcinoma M Selmansberger1, A Feuchtinger2, L Zurnadzhy3, A Michna1, JC Kaiser4, M Abend5, A Brenner6, T Bogdanova3, A Walch2, K Unger1,7, H Zitzelsberger1,7 and J Hess1,7 A substantial increase in papillary thyroid carcinoma (PTC) among children exposed to the radioiodine fallout has been one of the main consequences of the Chernobyl reactor accident. Recently, the investigation of PTCs from a cohort of young patients exposed to the post-Chernobyl radioiodine fallout at very young age and a matched nonexposed control group revealed a radiation-specific DNA copy number gain on chromosomal band 7q11.23 and the radiation-associated mRNA overexpression of CLIP2. In this study, we investigated the potential role of CLIP2 as a radiation marker to be used for the individual classification of PTCs into CLIP2- positive and -negative cases—a prerequisite for the integration of CLIP2 into epidemiological modelling of the risk of radiation- induced PTC. We were able to validate the radiation-associated CLIP2 overexpression at the protein level by immunohistochemistry (IHC) followed by relative quantification using digital image analysis software (P = 0.0149). Furthermore, we developed a standardized workflow for the determination of CLIP2-positive and -negative cases that combines visual CLIP2 IHC scoring and CLIP2 genomic copy number status. In addition to the discovery cohort (n = 33), two independent validation cohorts of PTCs (n = 115) were investigated. High sensitivity and specificity rates for all three investigated cohorts were obtained, demonstrating robustness of the developed workflow.
    [Show full text]
  • Characterization of Slbag Genes from Solanum Lycopersicum and Its Function in Response to Dark-Induced Leaf Senescence
    plants Article Characterization of SlBAG Genes from Solanum lycopersicum and Its Function in Response to Dark-Induced Leaf Senescence Mingming He 1, Yu Wang 1,2, Mohammad Shah Jahan 1,3 , Weikang Liu 1, Abdul Raziq 1, Jin Sun 1,2, Sheng Shu 1,2 and Shirong Guo 1,2,* 1 College of Horticulture, Nanjing Agricultural University, Nanjing 210095, China; [email protected] (M.H.); [email protected] (Y.W.); [email protected] (M.S.J.); [email protected] (W.L.); [email protected] (A.R.); [email protected] (J.S.); [email protected] (S.S.) 2 Suqian Academy of Protected Horticulture, Nanjing Agricultural University, Suqian 223800, China 3 Department of Horticulture, Sher-e-Bangla Agricultural University, Dhaka 1207, Bangladesh * Correspondence: [email protected] Abstract: The Bcl-2-associated athanogene (BAG) family is a group of evolutionarily conserved cochaperones involved in diverse cellular functions. Here, ten putative SlBAG genes were identified in tomato. SlBAG2 and SlBAG5b have the same gene structure and conserved domains, along with highly similar identity to their homologs in Arabidopsis thaliana, Oryza sativa, and Triticum aestivum. The qPCR data showed that BAG2 and BAG5b were highly expressed in stems and flowers. Moreover, both genes were differentially expressed under diverse abiotic stimuli, including cold stress, heat stress, salt treatment, and UV irradiation, and treatments with phytohormones, namely, ABA, SA, MeJA, and ETH. Subcellular localization showed that SlBAG2 and SlBAG5b were located in the cell membrane and nucleus. To elucidate the functions in leaf senescence of BAG2 and BAG5b, the full- Citation: He, M.; Wang, Y.; Jahan, length CDSs of BAG2 and BAG5b were cloned, and transgenic tomatoes were developed.
    [Show full text]
  • Challenges of New Discoveries of Clinical Applications Into The
    Challenges of new discoveries of clinical applications into the management of cancer patients Tomáš Zima, Veronika Mikulová Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine in Prague Czech Republic TUMOR MARKERS Tumor markers are defined as qualitative or quantitative alteration or deviation from normal of a molecule, substances, or process that can be detected by some type of assay above and beyond routine clinical and pathological evaluation. Tumor markers may be detected within malignant cells or surrounding stroma of a primary cancer, or in metastases in local (such as lymph nodes) or distant tissues, or either cellular-based or as soluble products in blood, secretions or excretions. Tumor markers have a very long research history ….. Discoveries of the best known tumor markers 1928 - Ascheim- Zondek hCG 1936 - Gutman PAP 1957 - Bjorklund TPA 1963 - Abelev AFP 1965 - Gold CEA 1979 - Koprowski CA 19-9 1979 - Wang PSA 1981 - Best CA 125 1983 - Kufe CA 15-3 ….. with many thousands of publications in the last four decades ….. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES* BY PHIL GOLD,$ M.D., AND SAMUEL O. FREEDMAN, M.D. (From the McGill University Medical Clinic, Montreal General Hospital, and the Department of Physiology, McGill University, Montreal, Canada) PLATES 35 TO 39 (Received for publication, November 16, 1964) ONLY A HANDFUL HAVE MOVED INTO CLINICAL PRACTICE TO DATE HER-2 CA 15-3
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • The Amazing Multi-Valency of the Hsp70 Chaperones
    Central JSM Cell & Developmental Biology Bringing Excellence in Open Access Review Article *Corresponding author Erik RP Zuiderweg, Department of Biological Chemistry, The University of Michigan Medical School, 1500 The Amazing Multi-Valency of Medical Center Drive, Ann Arbor, MI 48109, USA, Tel: 734-276-4463; Email: Submitted: 04 November 2016 the Hsp70 Chaperones Accepted: 20 November 2016 Erik RP Zuiderweg1* and Jason E. Gestwicki2 Published: 22 November 2016 1Department of Biological Chemistry, The University of Michigan Medical School, USA ISSN: 2379-061X 2Institute for Neurodegenerative Disease, University of California at San Francisco, Copyright USA © 2016 Zuiderweg et al. OPEN ACCESS Abstract Hsp70 proteins are keys to maintaining intra-cellular protein homeostasis. To carry Keywords out this task, they employ a large number of co-chaperones and adapter proteins. Here • Hsp70 proteins we review what is known about the interaction between the chaperones and partners, • Protein chaperones with a strong slant towards structural biology. Hsp70s in general and Hsc70 (HSPA8) in particular, display an amazing array of interfaces with their protein co-factors. We also reviewed the known interactions between Hsp70s and active compounds that may become leads towards Hsp70 modulation for treatment of a variety of diseases. INTRODUCTION misfolded proteins to favor protein (re)folding cycles [6]; (ii) transporting unfolded proteins through membranes to enable Hsp70 chaperones are highly conserved in all kingdoms; delivery of cargo to organelles [7]; (iii) recruiting proteins to in animals, they are an important member of the collection of the proteasome for turnover [8] and (iv) bringing proteins to protein chaperones including Hsp60, Hsp70, Hsp90 and small Hsps [1].
    [Show full text]
  • Investigations Into the Cellular Interactome of the PB2 Protein Expressed by Seasonal and Highly Pathogenic Avian Influenza Viruses
    Investigations into the cellular interactome of the PB2 protein expressed by seasonal and highly pathogenic avian influenza viruses D i s s e r t a t i o n zur Erlangung des akademischen Grades d o c t o r r e r u m n a t u r a l i u m (Dr. rer. nat.) im Fach Biologie eingereicht an der Lebenswissenschaftlichen Fakultät der Humboldt-Universität zu Berlin von Ulrike Arnold Präsidentin der Humboldt-Universität zu Berlin Prof. Dr.-Ing. Dr. Sabine Kunst Dekan der Lebenswissenschaftlichen Fakultät Prof. Dr. Bernhard Grimm Gutachter: 1. Prof. Andreas Herrmann 2. PD Thorsten Wolff 3. Dr. Benedikt Beckmann Tag der mündlichen Prüfung: 10.07.2018 Abstract Influenza virus replication relies on the functionality of its trimeric RNA dependent RNA polymerase complex under the conditions provided by the infected cell. PB2 is an essential component of this complex and is known to be a key factor for influenza virus host range. Given its importance, the interplay of PB2 with the cellular host proteome was investigated in several studies and various interaction partners such as protein phosphatase 6 (PP6) have been reported. However, these studies were mostly performed with laboratory/mouse- adapted strains or in the context of transiently transfected cells. Here, a combined affinity-purification/mass spectrometric approach was performed to identify novel interaction partners of PB2 of seasonal and highly pathogenic viral strains in infected human alveolar epithelial cells (A549). The subsequent analysis of selected cellular interaction partners aimed to determine the influence of these proteins on the replication cycle of these non-laboratory adapted viral strains.
    [Show full text]
  • Validation of the Hsp70–Bag3 Protein–Protein Interaction As a Potential Therapeutic Target in Cancer Xiaokai Li1, Teresa Colvin2, Jennifer N
    Small Molecule Therapeutics Molecular Cancer Therapeutics Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer Xiaokai Li1, Teresa Colvin2, Jennifer N. Rauch1, Diego Acosta-Alvear3, Martin Kampmann4, Bryan Dunyak1, Byron Hann5, Blake T. Aftab5, Megan Murnane5, Min Cho4, Peter Walter3, Jonathan S. Weissman4, Michael Y. Sherman2, and Jason E. Gestwicki1 Abstract Hsp70 is a stress-inducible molecular chaperone that is this PPI, indeed has antiproliferative activity (EC50 values required for cancer development at several steps. Targeting between 0.3 and 4 mmol/L) across cancer cell lines from theactivesiteofHsp70hasprovenrelativelychallenging, multiple origins. JG-98 destabilized FoxM1 and relieved sup- driving interest in alternative approaches. Hsp70 collaborates pression of downstream effectors, including p21 and p27. On with the Bcl2-associated athanogene 3 (Bag3) to promote cell the basis of these findings, JG-98 was evaluated in mice for survival through multiple pathways, including FoxM1. There- pharmacokinetics, tolerability, and activity in two xenograft fore, inhibitors of the Hsp70–Bag3 protein–protein interac- models. The results suggested that the Hsp70–Bag3 interac- tion (PPI) may provide a noncanonical way to target this tion may be a promising, new target for anticancer therapy. chaperone. We report that JG-98, an allosteric inhibitor of Mol Cancer Ther; 14(3); 642–8. Ó2015 AACR. Introduction bind to Hsp70 and help guide its chaperone functions. Of these cochaperones, Bag3 is of particular interest as an anticancer target HSP70 (Hsp70/HSPA1A) is a molecular chaperone that plays because it is selectively upregulated in response to stress (10) and important roles in protein homeostasis and cell survival (1).
    [Show full text]